“…I3C cyclic tetrameric derivative CTet (5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2- b :4,5- b' :7,8- b" :10,11- b'" ]tetraindole) (Figure 1 ) is an anticancer molecule that has been shown to exert interesting antiproliferative activity in both MCF-7 and MDA-MB-231 breast cancer cell lines [ 20 ]. Lucarini and colleagues [ 21 ] have optimized a straightforward, reproducible, and scalable CTet synthesis. Moreover, to improve bioavailability, they have optimized a formulation that is based on gamma-cyclodextrin (γ-CD) aqueous solution and that is about 10-fold more active with respect to the first preparation [ 20 ].…”